Skip to main content
Top
Published in: Clinical and Experimental Nephrology 3/2014

01-06-2014 | Erratum

Erratum to: Decreased urinary calbindin 1 levels in proteinuric rats and humans with distal nephron segment injuries

Authors: Tomoko Iida, Hidehiko Fujinaka, Bo Xu, Ying Zhang, Sameh Magdeldin, Masaaki Nameta, Zan Liu, Yutaka Yoshida, Eishin Yaoita, Shuichi Tomizawa, Akihiko Saito, Tadashi Yamamoto

Published in: Clinical and Experimental Nephrology | Issue 3/2014

Login to get access

Excerpt

One of the affiliations of the co-author Sameh Magdeldin was omitted in the original publication of this article. That affiliation is shown below. …
Metadata
Title
Erratum to: Decreased urinary calbindin 1 levels in proteinuric rats and humans with distal nephron segment injuries
Authors
Tomoko Iida
Hidehiko Fujinaka
Bo Xu
Ying Zhang
Sameh Magdeldin
Masaaki Nameta
Zan Liu
Yutaka Yoshida
Eishin Yaoita
Shuichi Tomizawa
Akihiko Saito
Tadashi Yamamoto
Publication date
01-06-2014
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 3/2014
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-013-0846-0

Other articles of this Issue 3/2014

Clinical and Experimental Nephrology 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine